Business Wire

A2RL

28.4.2024 13:58:27 CEST | Business Wire | Press release

Share
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit

TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire)

Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000 spectators at the circuit and captured the attention of over 600,000 online viewers in just 12 hours. Organized by ASPIRE, a subsidiary of Abu Dhabi’s Advanced Technology Research Council (ATRC), A2RL fuses extreme autonomous racing and AI to accelerate the global development of autonomous systems and technologies.

Following months of meticulous preparation spent refining driving AI algorithms in simulations, A2RL’s customized Dallara Super Formula SF23 cars tested the limits of human ingenuity and AI capability. Each team utilized an identical Super Formula race car - the fastest open-wheel race car in the world after Formula One- adapted for autonomous racing by the Technology Innovation Institute (TII), a sister company of ASPIRE.

Teams faced a complex task in coding. From understanding grip levels, managing tire temperatures, predicting opponent movements, performing successful overtakes, and operating the SF23 right at the limit of grip, the AI needed to perform all the things that racing drivers do intuitively. Additionally, with four autonomous cars racing on the track simultaneously, it marked a world-first attempt that added another layer of challenge.

In a last-lap shootout, the German outfit TUM snatched first place in a daring overtake when front-running Italian team UNIMORE slowed down and came to a stop on the track. The team was congratulated on the racetrack by H.H. Theyab bin Mohamed bin Zayed, who presented the Championship Trophy, along with H.E. Faisal Al Bannai, Secretary General, ATRC, and Strategic Research & Advanced Technology Affairs Advisor to the UAE President.

Simon Hoffmann, Team Principal, said: “This event has been nothing short of extraordinary, and the finale was our defining moment. We are absolutely thrilled with the outcome; it speaks volumes about our collective engineering prowess, coding expertise, and sheer determination. It's a testament to the incredible power of AI driving the evolution of autonomous mobility into the future!"

Spectators also enjoyed the riveting AI versus Human Race, where the Technology Innovation Institute (TII), pitted its autonomous car against renowned Formula One driver Daniil Kvyat. While Kvyat managed to hold his own and edge past his autonomous adversary by 10.38 secs, the spectacular 45-minute race highlighted just how close the autonomous race car performs against a human driver.

H.E. Al Bannai, said: “Through the Abu Dhabi Autonomous Racing League, we've sparked a race revolution. Showcasing fully autonomous racecars competing wheel-to-wheel, we've redefined the UAE's role in innovation and set a bold precedent for global mobility. This event isn't just a race; it's a transformative moment where technology, imagination, and ambition converge. A2RL serves as a beacon, inspiring the next generation through physical and virtual realities, while shaping a future where the impossible becomes achievable."

H.E. Dr. Sultan Al Jaber, Minister of Industry and Advanced Technology, and Group MD & CEO of ADNOC, as Title Sponsor, said: “Advances in artificial intelligence promise to transform every industry. The A2RL demonstrates the application of AI and as title sponsor, ADNOC is proud to help push the frontiers of science and innovation.”

Stephane Timpano, CEO of ASPIRE, said: “The launch of A2RL has reshaped the landscape of sports and technology, leaving a lasting impact for years to come. Moving forward, we're broadening our focus to include different vehicle types, while actively attracting top talent worldwide to showcase their mettle.”

On the sidelines of the main event, the A2RL STEM Challenge for high-school and undergrad students between the ages of 14 and 21 drew the participation of 18 local schools, in addition to an international entry from the Boys and Girls Club from Southeastern Michigan, to showcase their knowledge, skills, and innovation by racing 1:8 scale autonomous cars. The winner of the A2RL STEM Challenge was Heriot-Watt University.

A2RL pioneered the integration of mixed and virtual reality elements for the first time in autonomous racing. It gave each of the eight finalist teams a unique avatar persona and incorporated state-of-the-art Virtual Reality (VR) technology ahead of F1 implementation, igniting enthusiastic fan experience both online and offline. Fans at the event in Yas Marina Circuit got to enjoy insightful STEM workshops, intriguing VR challenges, Gran Turismo simulators, doodle cars, and a Raceum AI Museum, among other activities. The inaugural event concluded with a spectacular display of fireworks and drones, illuminating the iconic Yas Marina Circuit.

A2RL 2024 was successfully supported by ADNOC as Title Sponsor, and leading partners, including Du, DMT, AWS, and Mubadala, who played pivotal roles in shaping the event’s trajectory.

Details of the eight participating teams and other updates can be found at A2RL.io.

Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240428292385/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 07:30:00 CEST | Press release

SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye